Efficacy of PeaNoc XL tablets on inflammatory cytokines
TNF-α, pain
INFLAMMATION
The values are presented as mean±SD. Significance levels are denoted as follows: P<0.01* (significant), P<0.05** (significant), and P<0.001*** (highly significant).The levels of inflammatory cytokines, including TNF-α, IL-6, IL-1β, and CRP, were assessed using the ELISA technique. The addition of PeaNoc XL to standard therapy resulted in a significant reduction in the levels of TNF-α (P<0.01), IL-6 (P<0.01), IL-1β (P<0.001), and CRP (P<0.01) among patients experiencing joint pain and inflammation. In contrast, the standard therapy group did not exhibit any notable difference compared to the baseline levels of these cytokines.